It is a pharma private limited company based in Indore, Madhya Pradesh, India, established in 2011.
2011 | Indore, Madhya Pradesh, India | ActiveSynthesis Pharmaceutical Private Limited, a active private limited company, was established on 30 November 2011 in Indore, Madhya Pradesh, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24232MP2011PTC027222. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Priyanka Kesharwani (Director), Sanjay Kumar Kesharwani (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 201,Ishwar Apartment, 80,Chandralok Colony,Saket Nagar, Indore, Madhya Pradesh, 452018.
U24232MP2011PTC027222
027222
30 November 2011
₹0.10 M
₹0.10 M
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Synthesis Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Priyanka Kesharwani | Director | 30 Nov 2011 | Current |
| Sanjay Kumar Kesharwani | Director | 30 Nov 2011 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Synthesis Pharmaceutical Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3.6% increase. The company also saw a slight improvement in profitability, with a 5.61% increase in profit. The company's net worth Soared by an impressive increase of 14.66%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Synthesis Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Synthesis Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Synthesis Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synthesis Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Synthesis Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Synthesis Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was recorded as a recent event.
Progress on Priyanka Kesharwani was appointed as a Director was appointed as a Director on 30 Nov 2011 & has been associated with this company since 14 years 3 days . was documented.
The activity Sanjay Kumar Kesharwani was appointed as a Director was appointed as a Director on 30 Nov 2011 & has been associated with this company since 14 years 3 days . was completed.
Synthesis Pharmaceutical Private Limited was registered on 30 Nov 2011 with Roc Gwalior & aged 14 years 3 days as per MCA records. was recorded as a recent event.
The CIN of Synthesis Pharmaceutical Private Limited is U24232MP2011PTC027222.
Synthesis Pharmaceutical Private Limited is headquartered at 201,Ishwar Apartment, 80,Chandralok Colony,Saket Nagar, Indore, Madhya Pradesh, 452018.
Synthesis Pharmaceutical Private Limited was incorporated on 30 November 2011.
The current directors of Synthesis Pharmaceutical Private Limited are
The primary industry of Synthesis Pharmaceutical Private Limited is Pharma.
Synthesis Pharmaceutical Private Limited is unlisted.
The authorized capital of Synthesis Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Synthesis Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX